Photo: Irrazabal Studio/Shutterstock
A survey released by the University of Brasilia on Wednesday shows that antiretroviral drug atazanavir — typically prescribed to treat HIV — could reduce viral load in people infected with the coronavirus. Researchers hope this could lead to faster recovery for Covid-19 patients.
Researchers say atazanavir-based treatment could help lower the number of hospitalizations of people with severe Covid-19 infections — but further trials remain necessary before efficacy can be proven.
The study results were published in the Journal of the Brazilian Chemical Society.
Who is Magda Chambriard, the next CEO of Petrobras? This week, Jean Paul Prates stepped…
Data from the 2022 Census released today by the Brazilian Institute of Geography and Statistics…
Much has changed since President Luis Abinader of the Dominican Republic first came to prominence…
The Federal Prosecution Office said the investigation into a coup attempt led by former far-right…
Following the interest rate easing cycle initiated by the Brazilian Central Bank’s Monetary Policy Committee…
Brazil’s Senate on Wednesday approved a lackluster bill with regulations for climate change adaptation plans,…